Abiopharma

News list

Zuga Matt 🔴 sold 6.9K shares of Acumen Pharmaceuticals, Inc. (ABOS) at $1.82 Transaction Date: Jan 08, 2026 | Filing ID: 001898

Full text

News bot Jan. 12, 2026, 11:54 p.m.
🔍 Zuga Matt (Executive)

Company: Acumen Pharmaceuticals, Inc. (ABOS)

Report Date: 2026-01-08
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 6,888
Detailed Transactions and Holdings:
- Sold 6,888 shares of Common Stock at $1.8166 per share (Direct)
  Date: 2026-01-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 209,951.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 30, 2025.
- F2: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.7200 to $1.9500. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.